Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults 9-12-2025, 20:00

India-focused private debt AUM on course to surpass $18bn by end of 2024 — Preqin reports 26-09-2024, 10:30

Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma 24-03-2025, 10:53